ResMed Inc. (RMD)
NYSE · Healthcare
ResMed Inc. EBITDA 2009–2025
ResMed Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- ResMed Inc. ebitda for the quarter ending March 31, 2026 was 558.8 M, a 18.91% increase year-over-year.
- ResMed Inc. ebitda for the twelve months ending March 31, 2026 was 2.1 B, a 26.37% increase year-over-year.
- ResMed Inc. annual ebitda for 2025 was 1.9 B, a 25.86% increase from 2024.
- ResMed Inc. annual ebitda for 2024 was 1.5 B, a 15.40% increase from 2023.
- ResMed Inc. annual ebitda for 2023 was 1.3 B, a 11.82% increase from 2022.
- ResMed Inc. annual ebitda for 2022 was 1.2 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ResMed Inc. EBITDA — FAQ
ResMed Inc. (RMD) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RMD's ebitda history?
The chart and table above show ResMed Inc.'s ebitda by year and by quarter, including the growth rate.